Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Neogenomics Inc
F:NG9

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
F:NG9
Watchlist
Price: 12.585 EUR -0.24% Market Closed
Market Cap: €1.6B
Write Note Create Alert Ask AI

Wall St Price Targets

NG9 Price Targets Summary
Neogenomics Inc

Wall Street analysts forecast NG9 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NG9 is 9.645 EUR with a low forecast of 6.978 EUR and a high forecast of 16.487 EUR.

NG9 Lowest Forecast
6.978 EUR
-45% Downside
NG9 Average Forecast
9.645 EUR
-23% Downside
NG9 Highest Forecast
16.487 EUR
31% Upside
Lowest Forecast
Price Target
6.978 EUR
45% Downside
Average Forecast
Price Target
9.645 EUR
23% Downside
Highest Forecast
Price Target
16.487 EUR
31% Upside
Neogenomics Inc Competitors:
Price Targets
T
LPA
Two
130% Upside
UI
Ubiquiti Inc
57% Upside
AGCO
AGCO Corp
15% Upside
BWXT
BWX Technologies Inc
40% Upside
T
LPA
Two
130% Upside
UI
Ubiquiti Inc
57% Upside
AGCO
AGCO Corp
15% Upside
BWXT
BWX Technologies Inc
40% Upside

Revenue
Forecast

21% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
21% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 5 years is 9%.

What are analyst estimates?

Gross Profit
Forecast

21% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
21% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 5 years is 12%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
57%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
57%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss

What are analyst estimates?

Continue NG9 Research

Summary
NG9 intrinsic value, competitors valuation, and company profile.
DCF Valuation
NG9 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NG9 stock valuation using valuation multiples.
Wall St Estimates
NG9 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NG9 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Neogenomics Inc listings:
NASDAQ • USD
NEO
 SWB • EUR
NG9
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NG9's stock price target?
Price Target
9.645 EUR

According to Wall Street analysts, the average 1-year price target for NG9 is 9.645 EUR with a low forecast of 6.978 EUR and a high forecast of 16.487 EUR.

What is the Revenue forecast for Neogenomics Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 5 years is 9%.

What is the Gross Profit forecast for Neogenomics Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 5 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join 349,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett